The two companies have previously worked together, with Fintra’s trade finance platform already integrated into Aurionpro’s existing trade offerings.

Tachyus has announced a new contract with INEOS USA Oil & Gas (INEOS) to implement its Aurion platform. Aurion, a ...

Alcon Inc.'s strong growth, strategic acquisitions, and market leadership highlight its long-term potential. Read more on ALC ...

Tachyus has entered into an agreement with INEOS USA Oil & Gas LLC (INEOS) to deploy Aurion, its cloud-scalable platform for carbon accounting, monitoring, forecasting, and reporting. Aurion will ...

Delaware’s top court fast-tracked cross-appeals in IPO dispute Aurion delayed its public offering after missing SEC deadline Fast-tracked cross-appeals in Delaware by Alcon Research LLC and Aurion ...

Prominently featured in The Inner Circle, Greg Kunst is acknowledged as a Pinnacle Professional Member Inner Circle of Excellence for his contributions in the Biotech Industry. Greg Kunst stands at ...

Aurion Biotech has pushed out its CEO. Swiss healthcare company Alcon last week acquired a majority interest in Aurion, a clinical-stage startup in Seattle that is developing advanced cell ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

Please provide your email address to receive an email when new articles are posted on . Aurion will operate as a separate company. The Aurion board appointed Arnaud Lacoste, PhD, as CEO.

Leverages Alcon’s global scale with Aurion’s cell therapy expertise to accelerate U.S. Phase 3 development in fall of 2025 Aurion’s lead asset received Breakthrough Therapy Designation and ...

Eye care giant Alcon appears to have gained the upper hand in the ongoing power struggle with Aurion Biotech by securing a majority stake in the clinical-stage company and replacing its CEO.